You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin, Isophane

Showing 1 - 25 of 8,065
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial in Bobo-Dioulasso, Ouagadougou (premix insulin human isophane suspension and insulin human, Humulin N plus

Not yet recruiting
  • Type 1 Diabetes
  • premix insulin human isophane suspension and insulin human
  • Humulin N plus Humulin R
  • Bobo-Dioulasso, Houet, Burkina Faso
  • +2 more
Mar 12, 2023

Stroke, Ischemic, Mild Cognitive Impairment, Dementia, Vascular Trial in León (Dapagliflozin 10mg Tab, Statins (Cardiovascular

Recruiting
  • Stroke, Ischemic
  • +3 more
  • Dapagliflozin 10mg Tab
  • +3 more
  • León, Guanajuato, Mexico
    Hospital General de Zona IMSS 21
Oct 3, 2022

Diabetes, Type 2 Trial (Premixed Human Isophane Insulin Suspension + Human Insulin Injection, Premixed Insulin)

Completed
  • Diabetes Mellitus, Type 2
  • Premixed Human Isophane Insulin Suspension + Human Insulin Injection
  • Premixed Insulin
  • (no location specified)
Jan 23, 2021

Diabetes Trial in Neuss (Julphar Insulin N (human isophane insulin), Huminsulin® Basal (NPH, human isophane insulin))

Completed
  • Diabetes Mellitus
  • Julphar Insulin N (human isophane insulin)
  • Huminsulin® Basal (NPH, human isophane insulin)
  • Neuss, Germany
    Profil Neuss GmbH
Jul 1, 2020

Diabetes Trial in Portland (Switching to NPH insulin, Continuation of insulin glargine)

Withdrawn
  • Diabetes
  • Switching to NPH insulin
  • Continuation of insulin glargine
  • Portland, Oregon
    Providence Medical Group Northeast Clinic
Mar 7, 2020

Type1 Diabetes Trial in Neuss (Insulin glulisine (U300), Insulin glulisine, Insulin aspart)

Completed
  • Type1 Diabetes Mellitus
  • Insulin glulisine (U300)
  • +6 more
  • Neuss, Germany
    Investigational Site Number 276001
Apr 21, 2022

Diabetes, Type 2 Trial in Hong Kong (Insulin Glargine 300 UNT/ML, Neutral protamine hagedorn insulin)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin Glargine 300 UNT/ML
  • Neutral protamine hagedorn insulin
  • Hong Kong, Shatin, Hong Kong
    Prince of Wales Hospital
Aug 2, 2021

Type 2 Diabetes Trial in León (NPH insulin, Glargine and Lispro insulin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • NPH insulin
  • Glargine and Lispro insulin
  • León, Guanajuato, Mexico
    Hospital General de León
Nov 3, 2021

Mild Cognitive Impairment, Cognitive Impairment Trial in Winston-Salem (drug, other, device)

Active, not recruiting
  • Mild Cognitive Impairment
  • Cognitive Impairment
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jan 27, 2023

Gestational Diabetes, Diabetes, Type 2 Trial in Los Angeles (Insulin Detemir, Insulin NPH)

Recruiting
  • Gestational Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin Detemir
  • Insulin NPH
  • Los Angeles, California
    University of California, Los Angeles
Apr 25, 2022

Hyperglycemia Trial (Human insulin isophane, Humulin N (Eli Lilly), Standard of care, Insulin lispro, Humalog (Eli Lilly) in

Completed
  • Hyperglycemia
  • Human insulin isophane, Humulin N (Eli Lilly)
  • +2 more
  • (no location specified)
Feb 17, 2019

Type 1 Diabetes With Hypoglycemia, type1diabetes Trial in Cairo (Degludec, Glargine, NPH insulin)

Recruiting
  • Type 1 Diabetes Mellitus With Hypoglycemia
  • type1diabetes
  • Cairo, Egypt
    Ain Shams University
Feb 12, 2021

Mild Cognitive Impairment, Cognitive Impairment Trial in Winston-Salem (20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly &

Active, not recruiting
  • Mild Cognitive Impairment
  • Cognitive Impairment
  • 20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
  • 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Nov 2, 2021

Diabetes, Type 2, Diabetes, Type 1 Trial in New York, Mainz (3 hours humulin R 100 IU/mL PIT, 2 hours humulin R 100 IU/mL PIT)

Completed
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus, Type 1
  • 3 hours humulin R 100 IU/mL PIT
  • 2 hours humulin R 100 IU/mL PIT
  • New York, New York
  • +1 more
Mar 30, 2021

Diabetes, Lipohypertrophy Trial in Vancouver (Insulin lispro)

Suspended
  • Diabetes Mellitus
  • Lipohypertrophy
  • Insulin lispro
  • Vancouver, British Columbia, Canada
    University of British Columbia - Gerontology Research Lab
Apr 26, 2021

Hyperglycemia Steroid-induced, Insulin Resistance, Diabetes Trial in Chicago (NPH Insulin, glargine, Insulin Aspart)

Terminated
Has Results
  • Hyperglycemia Steroid-induced
  • Insulin Resistance, Diabetes
  • NPH Insulin
  • +2 more
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine
Aug 25, 2020

Diabetic Ketoacidosis Trial in Atlanta, Minneapolis (insulin glargine+ glulisine, NPH + Regular insulin)

Completed
Has Results
  • Diabetic Ketoacidosis
  • insulin glargine+ glulisine
  • NPH + Regular insulin
  • Atlanta, Georgia
  • +1 more
Aug 30, 2018

Hyperglycemia Trial in Vienna (Insulin lispro, Humalog (Eli Lilly) in insulin pump, Human insulin isophane, Humulin N (Eli

Completed
  • Hyperglycemia
  • Insulin lispro, Humalog (Eli Lilly) in insulin pump
  • +2 more
  • Vienna, Austria
    Medical University of Vienna
Jun 5, 2018

Diabetes Trial in Trondheim (metformin+ NPH insulin, metformin + sitagliptin +/- repaglinide)

Completed
  • Diabetes
  • metformin+ NPH insulin
  • metformin + sitagliptin +/- repaglinide
  • Trondheim, Norway
    Valdemar Grill
Jan 8, 2020

Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)

Not yet recruiting
  • Central Insulin Resistance
  • +2 more
  • Human nasal insulin
  • Placebo
  • (no location specified)
May 12, 2023

Diabetes Trial (Insulin Degludec and Insulin Aspart)

Not yet recruiting
  • Diabetes
  • Insulin Degludec and Insulin Aspart
  • (no location specified)
Apr 4, 2023

Education, Patient Trial in Izmir (Video-assisted training)

Active, not recruiting
  • Education, Patient
  • Video-assisted training
  • İzmir, Menemen, Turkey
    izmir Bakircay University
Jun 21, 2023

To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in

Completed
  • To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
  • Glargine and regular insulin versus NPH and regular insulin
  • Lahore, Punjab, Pakistan
    Pediatric endocrine and diabetes section, Pediatric department,
Jan 29, 2023

Type 1 Diabetes Trial (Semaglutide weekly injection)

Not yet recruiting
  • Type 1 Diabetes
  • Semaglutide weekly injection
  • (no location specified)
Sep 21, 2023

Insulin Resistance, Polycystic Ovary Syndrome, Hyperinsulinism Trial in Houston

Not yet recruiting
  • Insulin Resistance
  • +4 more
    • Houston, Texas
      Lilli Health
    Jul 10, 2023